BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17435159)

  • 1. Salivary protein/peptide profiling with SELDI-TOF-MS.
    Schipper R; Loof A; de Groot J; Harthoorn L; van Heerde W; Dransfield E
    Ann N Y Acad Sci; 2007 Mar; 1098():498-503. PubMed ID: 17435159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
    Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
    Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.
    Papale M; Pedicillo MC; Di Paolo S; Thatcher BJ; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    Clin Chem Lab Med; 2008; 46(1):89-99. PubMed ID: 18020972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
    Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
    Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
    Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
    Streckfus CF; Bigler LR; Zwick M
    J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of NaCl and sucrose tastants on protein composition of oral fluid analysed by SELDI-TOF-MS.
    Silletti E; Bult JH; Stieger M
    Arch Oral Biol; 2012 Sep; 57(9):1200-10. PubMed ID: 22541734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents.
    Hardt M; Witkowska HE; Webb S; Thomas LR; Dixon SE; Hall SC; Fisher SJ
    Anal Chem; 2005 Aug; 77(15):4947-54. PubMed ID: 16053308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
    Penno MA; Ernst M; Hoffmann P
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.
    Shintani S; Hamakawa H; Ueyama Y; Hatori M; Toyoshima T
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):68-74. PubMed ID: 19896329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
    Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
    Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.
    Becker AM; Das S; Xia Z; Liu Z; Adam BL; Kountakis SE
    Am J Rhinol; 2008; 22(2):139-43. PubMed ID: 18416969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media.
    Szalowska E; van Hijum SA; Roelofsen H; Hoek A; Vonk RJ; te Meerman GJ
    Biotechnol Prog; 2007; 23(1):217-24. PubMed ID: 17269691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.